PB-722

N/A

Report date: 2024/01/04 15:49:31
NME

Base Information

Drug NamePB-722
Drug Alias NamePB-722PB722
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon receptor agonists
TargetsGlucagon receptor
Therapy Area/IndicationsCongenital Hyperinsulinism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPeg Bio Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesPeg Bio Co Ltd
Inactive CompaniesN/A
Active IndicationsCongenital Hyperinsulinism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A